Antipuesto, Nilda P.
HRN: 16-46-56 Sex: FemalePatient Encounter
AMS Audit List
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
10/05/2023
CEFTRIAXONE 1G (VIAL)
10/05/2023
10/11/2023
IVT
2g
OD
CAP MR
Checking Final Appropriateness
02/07/2024
CEFTRIAXONE 1G (VIAL)
02/07/2024
02/13/2024
IVT
2g
OD
UTI
Waiting Final Action